TY - JOUR
T1 - Salmeterol Xinafoate
T2 - An Analysis of Outcomes and Cost-Effectiveness Using a Primary Care Database
AU - Price, David
AU - CARGILL, K.
AU - Wolfe, S.
AU - DARBY, H.
N1 - Acknowledgements
The authors wish to thank Leanne Rice of GlaxoWellcome U.K. for statistical analysis and GWUK for supporting the
writing of the manuscript.
PY - 1998
Y1 - 1998
N2 - Long-acting inhaled /&-agonists (LABS), used in conjunction with low-dose inhaled steroids, are a recommended alternative to high-dose inhaled steroids for asthmatics with persistent symptoms (1). There are, however, few published data regarding their cost-effectiveness. The drugs are relatively expensive and the aim of this study was to evaluateLAB cost-effectiveness in primary care, in terms of improved clinical outcomes (associated with reduced NHS costs) offsetting higher prescription costs. A controlled, retrospective, non-randomized analysis utilized the computerized Thorpewood Primary Care Database and compared clinical outcomes and asthma management costs 1 yr prior to and 1 yr after initiation of therapy with salmeterolxinafoate.
AB - Long-acting inhaled /&-agonists (LABS), used in conjunction with low-dose inhaled steroids, are a recommended alternative to high-dose inhaled steroids for asthmatics with persistent symptoms (1). There are, however, few published data regarding their cost-effectiveness. The drugs are relatively expensive and the aim of this study was to evaluateLAB cost-effectiveness in primary care, in terms of improved clinical outcomes (associated with reduced NHS costs) offsetting higher prescription costs. A controlled, retrospective, non-randomized analysis utilized the computerized Thorpewood Primary Care Database and compared clinical outcomes and asthma management costs 1 yr prior to and 1 yr after initiation of therapy with salmeterolxinafoate.
U2 - 10.1016/s0954-6111(98)90232-3
DO - 10.1016/s0954-6111(98)90232-3
M3 - Article
C2 - 9926144
VL - 92
SP - 1302
EP - 1304
JO - Respiratory Medicine
JF - Respiratory Medicine
SN - 0954-6111
ER -